Skip to main content

Table 2 Changes in methadone patient in-person treatment

From: Patient experiences of methadone treatment changes during the first wave of COVID-19: a national community-driven survey

Changes in Patient Treatment

Before COVID-19

During COVID-19

P-value

Take-home doses

  

 < 0.001

28-day take-home doses

6.9% (27)

24.2% (95)

 

14 to 21-day take-home doses

15.1% (59)

28.8% (113)

 

2 to 7-day take-home doses

50.5% (198)

30.9% (121)

 

None or 1 take-home doses

22.4% (88)

10.2% (40)

 

Declined to state

5.1% (20)

5.9% (23)

 

Clinic attendance

  

 < 0.001

Never

0%

0.8% (3)

 

Two or less times a month

21.2% (83)

53.3% (209)

 

Once a week

26% (102)

17.9% (70)

 

2–6 times a week

19.9% (78)

9.9% (39)

 

Everyday

27.8% (109)

13.5% (53)

 

Declined to state

5.1% (20)

4.6% (18)

 

Drug testing

  

 < 0.001

Less than once a month

0.3% (1)

2.8% (11)

 

1–2 times a month

76.5% (300)

71.4% (280)

 

2 or more times a month

13.3% (52)

10.5% (41)

 

Random

3.1% (12)

2.6% (10)

 

Never

1.3% (5)

9.2% (36)

 

Counseling

  

 < 0.001

In person

82.9% (325)

19.4% (76)

 

Telehealth

3.3% (13)

61.7% (242)

 

Not required

8.2% (32)

14% (55)

 

Decline to state

5.6% (22)

4.8% (19)

Â